Welcome to our dedicated page for MICROMEM TECHNOLOGIES SEC filings (Ticker: MMTIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MICROMEM TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MICROMEM TECHNOLOGIES's regulatory disclosures and financial reporting.
Micromem Technologies Inc. reported progress on developing and commercializing its proprietary gas sensing technology. Engineering work continues on a wearable gas sensing platform, with demonstration prototypes expected by the fall of 2026, and on a complementary fixed-position gas detection platform for continuous environmental monitoring.
Independent research cited by Micromem estimates the combined North American and European market for portable gas detection systems at US$1.185 billion annually, and the fixed gas detection market at US$2.29 billion annually. Management believes the wearable platform represents an initial commercialization opportunity of about US$50 million annually, focused on defense and oil and gas applications. The company is prioritizing protection of its intellectual property through patents and continues collaborations with Defence Research and Development Canada and the University of Toronto. Shares issued total 649,099,645.
Micromem Technologies Inc. reports another loss-making quarter and highlights material uncertainty about its ability to continue as a going concern. For the three months ended April 30, 2026, the company posted a net and comprehensive loss of $357,754, bringing the six‑month loss to $720,759. Cash fell to $28,464 against current liabilities of $5,843,385, resulting in a working capital deficit of $5,784,058. Convertible debentures of $4,630,519 plus derivative and warrant liabilities dominate a small asset base of $85,131. Management continues to fund operations through new debentures and equity units while pursuing commercialization of its nanowire sensor collaborations with the University of Toronto, but states there is substantial doubt about the company’s ability to continue as a going concern without additional financing and successful commercialization.
Micromem Technologies Inc. filed a Form 6-K providing an update on its wearable sensing platform being evaluated for defence and security uses. The company completed an initial cost and engineering review and reports that the current prototype meets its design targets.
The device is designed to weigh less than 250 grams and have an anticipated cost of under $1,000 CAD per unit, while maintaining required functionality and performance. Micromem anticipates that the Department of National Defence opportunity could support an initial annual order of approximately 5,000 units and plans to submit the design to foreign militaries later this year.
The company will proceed to the next stage of development and construction of the wearable platform for demonstration purposes, targeting military, security, and first-responder applications that require real-time sensing and monitoring in demanding environments.
Micromem Technologies Inc. closed a non-brokered private placement, raising gross proceeds of approximately C$235,000. The company issued 9,400,000 units at C$0.025 per unit, with each unit consisting of one common share and one warrant exercisable at C$0.05 per share for two years.
A total of 9,400,000 common shares and 9,400,000 warrants were issued, and all securities are subject to a four-month hold period. No insiders participated; all subscribers are at arm’s length. Micromem plans to use the net proceeds for working capital. Shares issued total 649,099,645.
Micromem Technologies Inc. reports that discussions with Canada’s Department of National Defence have progressed toward unit-level commercialization and deployment planning for its wearable environmental sensing platform under an existing collaborative research agreement with the University of Toronto and DND. The defence representatives have asked Micromem to prepare preliminary per-unit cost models and commercialization framework materials focused on real-time environmental monitoring and personnel safety applications. The platform is intended for distributed sensing and real-time intelligence across defence, industrial safety, infrastructure monitoring and related markets. Micromem views this as an important step in evaluating scalable deployment opportunities and continues to build relationships with government, academic and industrial partners. Shares issued are 639,699,645.
Micromem Technologies Inc. reports that Canada’s Department of National Defence has approved go-forward plans for the next phase of its wearable gas sensing development project, conducted under a collaborative research agreement with the University of Toronto. This phase centers on completing functional wearable prototypes and expanding the university-based R&D team with two new members focused on software, hardware, and system miniaturization for the gas sensing platform.
The work targets integration of Micromem’s proprietary nanowire field-effect transistor gas sensors into low-power, field-deployable wearable systems designed to meet defense performance needs while supporting broader commercial uses. The company highlights potential dual-use applications in defense, industrial safety, environmental monitoring, and personal protection. Micromem notes that 635,463,983 shares were issued and outstanding and reiterates typical forward-looking statement risk factors.
Micromem Technologies Inc. filed a Form 6-K highlighting progress on its wearable gas sensing project. The company has engaged two engineering students from the University of Toronto to work with the university’s team under a collaborative research agreement with the Department of National Defence.
This phase focuses on software and hardware needed for low-power, wearable architectures that adapt Micromem’s ultra-high sensitivity nanowire gas-sensing technology for real-world, field use. The company anticipates this work will lead to functional wearable prototypes, followed by validation testing with defense stakeholders and potential commercial partners. Micromem reports 634,081,495 shares issued.
Micromem Technologies Inc. reports progress on its gas-phase sensor program under a collaborative research agreement with the Department of National Defence and the University of Toronto. The company is developing ultra-sensitive detection systems for wearable and portable platforms.
The sensing platform targets zeptofarad (10⁻²¹ farads) sensitivity, enabling detection of extremely small electrical changes when minute quantities of substances interact with the sensor. Potential uses include environmental monitoring, industrial safety, healthcare diagnostics, energy infrastructure monitoring, and defense applications.
Micromem is refining sensor architecture, signal processing, and system integration to support compact, low-power, wearable units aligned with military-grade field requirements. The company plans to evaluate application opportunities and strategic partnerships to move the technology toward military and commercial deployment. Shares issued total 626,013,781.
Micromem Technologies Inc. filed an update describing progress on its liquid-phase nanowire field-effect transistor (NWFET) biochemical sensor, developed under a collaboration with the University of Toronto and Canada’s Department of National Defence. The platform targets highly sensitive detection of biochemical agents for both defence and medical uses.
The liquid-phase sensor has demonstrated detection of clinically relevant biomarkers tied to acute inflammation and infectious disease, including Angiopoietin-1, streptavidin-linked assays, and TREM-1 at low concentration levels. These results support moving to the next development phase, focusing on further biomarker validation and completing microfluidic integration, while complementing Micromem’s parallel gas-phase program and expanding potential applications into point-of-care diagnostics.
Micromem Technologies Inc. reports unaudited IFRS results for the three months ended January 31, 2026, showing a net loss of $363,005 versus net income of $437,452 a year earlier. There was no commercial revenue; results were driven by operating expenses, interest on convertible debentures, stock-based compensation of $177,914, and fair-value remeasurements of warrants and derivatives.
Operating cash outflow was $229,527, leaving cash of $223,423. Total assets were $272,211 against total liabilities of $5,898,868, producing a shareholders’ deficit of $5,626,657 and a working capital deficiency of $5,647,659. The company discloses material uncertainties that cast substantial doubt on its ability to continue as a going concern and notes continued reliance on $4,536,762 of convertible debentures plus warrant and derivative liabilities.
Management highlights progress in its collaboration with the University of Toronto, Defence Research and Development Canada and NSERC on nanowire-based gas and liquid biochemical sensors, targeting sensitive industrial and medical applications. During the quarter Micromem raised $164,106 through equity private placements and issued new convertible debentures, and subsequent events include further debenture financings, repayments and share conversions.